Literature DB >> 4994424

[First clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine].

D de Biolley, L Sorel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4994424

Source DB:  PubMed          Journal:  Acta Neurol Psychiatr Belg        ISSN: 0001-6284


× No keyword cloud information.
  4 in total

1.  Treatment of childhood epilepsy with dipropylacetic acid (DPA).

Authors:  I Lagenstein; H J Sternowsky; E Blaschke; M Rothe; R Fehr
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-10-09

2.  Electroencephalographic and behavioural effects of sodium valproate in patients with photosensitive epilepsy. A single dose trial.

Authors:  M S Myslobodsky; M Mintz; R Douglas
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

Review 3.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

4.  Metagenomic views of microbial dynamics influenced by hydrocarbon seepage in sediments of the Gulf of Mexico.

Authors:  Rui Zhao; Zarath M Summers; Glenn D Christman; Kristin M Yoshimura; Jennifer F Biddle
Journal:  Sci Rep       Date:  2020-04-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.